We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+1.91%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.7B
AUM Growth
+$101M
Cap. Flow
+$158M
Cap. Flow %
1.07%
Top 10 Hldgs %
22.11%
Holding
946
New
64
Increased
332
Reduced
304
Closed
69

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$57.5M
2
AZN icon
AstraZeneca
AZN
+$44.9M
3
ADSK icon
Autodesk
ADSK
+$43.5M
4
MELI icon
Mercado Libre
MELI
+$40.7M
5
AMGN icon
Amgen
AMGN
+$33.6M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$92.5M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$88M
3
BABA icon
Alibaba
BABA
+$73.8M
4
MRK icon
Merck
MRK
+$49.8M
5
MXIM
Maxim Integrated Products
MXIM
+$48.5M

Sector Composition

Rank Sector Weight
1 Healthcare 32.09%
2 Technology 24.53%
3 Financials 9.08%
4 Communication Services 8.24%
5 Consumer Discretionary 7.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.9T
$718M 4.88%
2,547,119
+61,035
+2% +$17.8M
GOOGL icon
2
Alphabet (Google) Class A
GOOGL
$4.25T
$496M 3.37%
3,712,220
+85,740
+2% +$11.7M
AAPL icon
3
Apple
AAPL
$4.76T
$478M 3.25%
3,378,792
-54,835
-2% -$8.07M
MRK icon
4
Merck
MRK
$317B
$275M 1.87%
3,663,179
-655,128
-15% -$49.8M
DHR icon
5
Danaher
DHR
$123B
$245M 1.66%
907,189
-64,185
-7% -$17.5M
AMGN icon
6
Amgen
AMGN
$199B
$236M 1.6%
1,109,804
+146,147
+15% +$33.6M
REGN icon
7
Regeneron Pharmaceuticals
REGN
$70.3B
$235M 1.6%
388,643
-141,703
-27% -$88M
TMO icon
8
Thermo Fisher Scientific
TMO
$193B
$209M 1.42%
365,815
+12,692
+4% +$6.97M
META icon
9
Meta Platforms (Facebook)
META
$1.6T
$191M 1.3%
563,478
+56,840
+11% +$20.5M
AMZN icon
10
Amazon
AMZN
$2.62T
$168M 1.14%
1,024,720
+189,240
+23% +$32.6M
JNJ icon
11
Johnson & Johnson
JNJ
$612B
$159M 1.08%
982,426
+337,232
+52% +$57.5M
SGEN
12
DELISTED
Seagen Inc. Common Stock
SGEN
$150M 1.02%
886,024
+44,207
+5% +$6.88M
UNH icon
13
UnitedHealth
UNH
$394B
$142M 0.96%
362,160
+18,867
+5% +$7.81M
GOOG icon
14
Alphabet (Google) Class C
GOOG
$4.25T
$137M 0.93%
1,028,680
+101,180
+11% +$13.9M
NVDA icon
15
NVIDIA
NVDA
$5.03T
$125M 0.85%
6,029,140
-318,700
-5% -$6.62M
RY icon
16
Royal Bank of Canada
RY
$295B
$124M 0.84%
1,246,769
-56,674
-4% -$5.78M
PG icon
17
Procter & Gamble
PG
$348B
$117M 0.8%
837,967
-30,666
-4% -$4.35M
V icon
18
Visa
V
$675B
$116M 0.79%
520,229
+44,061
+9% +$10.3M
ADBE icon
19
Adobe
ADBE
$88.3B
$115M 0.78%
200,161
-7,843
-4% -$4.94M
BAC icon
20
Bank of America
BAC
$431B
$114M 0.77%
2,676,331
+540,392
+25% +$21.8M
TRMB icon
21
Trimble
TRMB
$11.7B
$113M 0.77%
1,374,603
-4,883
-0.4% -$429K
GILD icon
22
Gilead Sciences
GILD
$164B
$109M 0.74%
1,557,611
-34,495
-2% -$2.42M
VRTX icon
23
Vertex Pharmaceuticals
VRTX
$121B
$108M 0.73%
592,829
-215,038
-27% -$42M
DIS icon
24
Walt Disney
DIS
$168B
$107M 0.73%
633,384
+131,599
+26% +$23.5M
ADSK icon
25
Autodesk
ADSK
$43.4B
$104M 0.7%
363,053
+141,974
+64% +$43.5M
1
2 3 4 5

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2021 Portfolio in Review

As of Q3 2021, Candriam SCA held 946 positions worth $14.7B, up 0.69% from $14.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA's Q3 2021 filing shows 64 new, 332 increased, 304 reduced and 69 closed positions. Its largest new stake was FIVE9: 86,075 shares worth $13.7M. The largest sale was Alexion Pharmaceuticals, an estimated $92.5M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q3 2021 buy was FIVE9: 86,075 shares worth $13.7M.
  • Candriam SCA added most to Johnson & Johnson in Q3 2021, an estimated $57.5M increase.
  • Candriam SCA's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $88M.
  • Candriam SCA fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $92.5M.
  • Candriam SCA's ten largest holdings make up 22% of its $14.7B portfolio in Q3 2021.
  • Candriam SCA opened 64 new positions and closed 69 in Q3 2021.
  • Candriam SCA's portfolio value rose 0.69% quarter-over-quarter to $14.7B.

Based on Candriam SCA's 13F filing for Q3 2021, filed 9 Nov 2021.